Sumitomo Pharma Co Ltd (STU:DPM)
€ 3.5 0.02 (0.57%) Market Cap: 1.41 Bil Enterprise Value: 3.06 Bil PE Ratio: 0 PB Ratio: 2.04 GF Score: 63/100

Sumitomo Dainippon Pharma Co Ltd ESG Briefing Transcript

Dec 18, 2020 / NTS GMT
Release Date Price: €10.3
Hiroshi Nomura
Sumitomo Dainippon Pharma Co., Ltd. - CEO, President & Representative Director

My Name is Hiroshi Nomura. I'm the President and CEO of Sumitomo Dainippon Pharma. Thank you for joining ESG meeting today. Thank you also for having interest in our company. Your feedback, comments and opinions are very important in managing the company. So I'm looking forward to the discussions today with you.

I would like to explain business model, materiality and corporate governance. After my presentation, Kimura-san will present R&D part, and Higuchi-san will present human resources, social contributions and environment.

This is my first slide regarding business model. On the left, you see 6 types of capital, intellectual capital, social and relationship capital, human capital, financial capital and manufactured capital. We use those capital in our strength in R&D, global platform and human resources. Capitalizing on those strengths, Sumitomo focuses on materiality that creates value and materiality that forms foundation for business continuity. These are very important in our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot